5% stakes
Great Point Partners
Institution
- 5% stake reports
- 23
- 5% stake stocks
- 14
- Latest report
- 26/09/11
5% stake reports
| Stock | ||
|---|---|---|
| Research Alliance Corp III RACC09/11 | 6.49%504,891 sh | First report |
| Jatt III Acquisition JTTT09/02 | 5.83%450,000 sh | First report |
| ProMIS Neurosciences PMN08/14 | 7.66%736,881 sh | −2.3pp |
| Amanat Acquisition AMAN08/14 | 6.67%500,000 sh | +1.5pp |
| Amanat Acquisition AMAN05/27 | 5.17%500,000 sh | First report |
| ProMIS Neurosciences PMN05/15 | 9.99%954,082 sh | +0.0pp |
| Context Therapeutics CNTX05/15 | 2.44%2,238,496 sh | −2.7pp |
| Zura Bio ZURA05/15 | 4.44%4,215,930 sh | −0.7pp |
| Jatt II Acquisition JATT04/24 | 6.41%500,000 sh | First report |
| Scynexis SCYX04/07 | 9.99%7,978,713 sh | First report |
| Sol-Gel Technologies SLGL03/31 | 8.45%274,363 sh | First report |
| Inventiva IVA02/17 | 3.49%6,783,269 sh | −2.6pp |
| Vistagen Therapeutics VTGN02/17 | 4.95%2,055,834 sh | −1.3pp |
| Vor Biopharma VOR02/17 | 3.3%1,370,107 sh | −2.3pp |
| Vor Biopharma VOR25/12/17 | 5.63%1,234,486 sh | First report |
| Unicycive Therapeutics UNCY25/11/14 | 4.51%796,558 sh | −1.7pp |
| Inventiva IVA25/11/14 | 6.06%8,636,151 sh | −1.4pp |
| Unicycive Therapeutics UNCY25/08/14 | 6.24%796,558 sh | −3.8pp |
| Outlook Therapeutics OTLK25/08/14 | 4.99%2,220,000 sh | −1.4pp |
| Inventiva IVA25/06/20 | 7.42%10,576,827 sh | First report |
